Amanote Research
Register
Sign In
SAT0073 MIR-186-5P Targeting IL-33 Gene as Biomarker to Predict Subclinical Atherosclerosis in Patients With Early Rheumatoid Arthritis
doi 10.1136/annrheumdis-2017-eular.2840
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
TH Cheng
Q Shang
WY Mak
M Li
KY Kwok
ICW Yim
EKM Li
PCH Wong
VWN Lao
HT Pang
LS Tam
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
Progression of Subclinical Atherosclerosis Over 5 Years in Patients With Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Characteristics and Clinical Associations of Arterial Stiffness and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
Kardiologiya
Cardiovascular Medicine
Cardiology
Biomarkers of Subclinical Atherosclerosis in Patients With Psoriatic Arthritis
Open Access Rheumatology: Research and Reviews
Rheumatology
AB0352 Risk Factors and Subclinical Atherosclerosis in Rheumatoid Arthritis Females Comorbid With Hypertension
A7.3 Association of Circulating miR-223 and miR-16 With Disease Activity in Patients With Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Neopterin in Patients With Early Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Early Atherosclerosis in Rheumatoid Arthritis: A Case Control Study
JMS SKIMS
P101 Systemic and Local IL-17A and miR-155 Levels in Rheumatoid Arthritis Patients
P100 Systemic and Local IL-17A and miR-146A Levels in Rheumatoid Arthritis Patients
